Login to Your Account

Hard Times in Capital Market Leave UK Stalwarts Vulnerable

By Nuala Moran

Wednesday, February 27, 2008
LONDON - Fallout from the malaise in the capital markets has hit the heart of UK biotech, with quoted companies Vernalis plc, Ardana plc and Medical Marketing International Group (MMI) plc announcing cutbacks and restructuring that leave all three open to acquisition. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription